---
figid: PMC10838672__MCO2-5-e474-g006
figtitle: Wnt on and Wnt off state of Wnt/B‐catenin signaling pathway and therapeutic
  strategies based on them
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10838672
filename: PMC10838672__MCO2-5-e474-g006.jpg
figlink: /pmc/articles/PMC10838672/figure/F4
number: F4
caption: 'Wnt on and Wnt off state of Wnt/β‐catenin signaling pathway and therapeutic
  strategies based on them. The Wnt/β‐catenin pathway is normally inactivated in the
  mature healthy liver, being the Wnt off state. However, Wnt/β‐catenin signaling
  is frequently overactivated in HCC and in the Wnt on state. Molecular inhibitors
  and antibodies currently in clinical trials mainly target FZD, LRP5/6, β‐catenin,
  and TCF. APC, adenomatous polyposis coli; Axin, scaffold protein axin; CK1, casein
  kinase 1; FZD, Frizzled; LRP5/6: lipoprotein reception‐associated protein; LEF,
  lymphoid enhancer‐binding protein family; TCF, T‐cell factor'
papertitle: 'Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy'
reftext: Xiaoting Luo, et al. MedComm (2020). 2024 Feb;5(2).
year: '2024'
doi: 10.1002/mco2.474
journal_title: MedComm
journal_nlm_ta: MedComm (2020)
publisher_name: John Wiley and Sons Inc.
keywords: hepatocellular carcinoma | immunotherapy | signaling pathways | targeted
  therapy
automl_pathway: 0.9593645
figid_alias: PMC10838672__F4
figtype: Figure
redirect_from: /figures/PMC10838672__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10838672__MCO2-5-e474-g006.html
  '@type': Dataset
  description: 'Wnt on and Wnt off state of Wnt/β‐catenin signaling pathway and therapeutic
    strategies based on them. The Wnt/β‐catenin pathway is normally inactivated in
    the mature healthy liver, being the Wnt off state. However, Wnt/β‐catenin signaling
    is frequently overactivated in HCC and in the Wnt on state. Molecular inhibitors
    and antibodies currently in clinical trials mainly target FZD, LRP5/6, β‐catenin,
    and TCF. APC, adenomatous polyposis coli; Axin, scaffold protein axin; CK1, casein
    kinase 1; FZD, Frizzled; LRP5/6: lipoprotein reception‐associated protein; LEF,
    lymphoid enhancer‐binding protein family; TCF, T‐cell factor'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - LRP5
  - LRP6
  - SERPINA4
  - CSNK1A1
  - KRT1
  - CSNK1A1L
  - CTNNB1
  - GSK3B
  - APC
  - PROC
  - AXIN1
  - AXIN2
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - HNF4A
  - Nucleus
  - PKF118-310
---
